ICON’s Cynthia Dukes Voted One Of The World’s Most Influential People In Vaccines

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cynthia Dukes is the only CRO representative included in an industry survey by VaccineNation

Dublin, Ireland, 16th September 2014 – ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that Cynthia Dukes, VP, Global Project Management, Vaccines, Infectious Disease, Women’s Health & Primary Care, has been voted one of the50 Most Influential People in Vaccines following a global industry survey conducted by vaccine industry organisation, VaccineNation. Cynthia was the only CRO representative included in the list.

Commenting on the announcement, Dr. Steve Cutler, Chief Operating Officer, ICON plc said: “We are very proud of Cindy’s achievements and are delighted that the vaccine industry recognises her in depth expertise as market-leading within the CRO industry. This latest recognition, coupled with ICON’s Best CRO award at the Vaccine Industry Awards earlier this year, is testament to the innovation our Vaccine Centre of Excellence is delivering to our customers to help them reduce their development costs and speed the delivery of important vaccines to patients worldwide.”

In April 2014, ICON was awarded the Best CRO in the Vaccine Industry Excellence Awards which honoured individuals, organisations and initiatives that have made significant contributions to innovation in the field of vaccines. ICON was selected by a panel of global biotechnology industry stakeholders as the best CRO according to the following criteria:

• Range of services provided in niche and core therapeutic areas.
• Methods of performance improvement or introduction of new services.
• Attention to and quality of relationships with clients.
• Reaching of milestones and final/ongoing outcomes.
• Building and maintaining existing and long-term partnerships.

ICON’s Vaccine Centre of Excellence offers a unique blend of industry expertise with enabling technologies, including Firecrest, ICONIK and ADDPLAN, to help customers identify and overcome the challenges associated with vaccine development. The team is led by Cynthia Dukes who has over 29 years of clinical research experience in vaccines, oncology and infectious disease. To date in ICON, Cynthia has provided strategic and management oversight on numerous pivotal studies leading to the approval of 7 vaccines and 5 oncology therapies.

About ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has approximately 11,000 employees, operating in 38 countries.

Further information is available at www.iconplc.com

ICON Media Contact
Rosie Ireland
Weber Shandwick
Tel: +44 (0) 207 067 0190
Email: rireland@webershandwick.com

Help employers find you! Check out all the jobs and post your resume.

Back to news